EASD to Feature Major Trial Results, Clinical Guidance The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more.

2025 ESC Congress HOT LINE sessions: key clinical studies From August 29 to September 1, 2025, the regular Congress of the European Society of Cardiology was held in Madrid (Spain), combined this year with the World Congress of Cardiology. The main theme of the event was "Global Health: Cardiology Without Borders".
This event brought together leading experts and researchers from different countries and allowed them to discuss new research and achievements in the treatment of cardiovascular diseases.

Cardioprogress Newsletter Dear Colleagues!
The Cardioprogress Foundation resumes publishing a quarterly newsletter dedicated to scientific news in cardiology. If you are interested in specific topics and details of scientific discoveries in the field of cardiology, please write to us. (The e-mail address is indicated on the last page of the newsletter).

Baxdrostat: A “Game Changer” for Hypertension? A new class of antihypertensive agent that blocks the production of aldosterone — a key hormone believed to drive increased blood pressure — has shown impressive results in one of the first pivotal phase 3 trials in patients with resistant or uncontrolled hypertension.

ACC Recommends Vaccination Against Respiratory Illness in Cardiovascular Disease Adults with heart disease should get vaccinated against a range of respiratory viruses, according to new clinical guidance from the American College of Cardiology.

New Type 2 Diabetes Guidance Ties Treatment Choice to Cardio-Renal Risk New guidance on preventing cardiovascular (CV) and renal complications in type 2 diabetes (T2D) emphasizes tailoring therapy to a patient’s individual risk profile.

ACC and AHA guidelines for the treatment of hypertension have been updated The target blood pressure level for adults remains below 130/80 mm Hg, but drug therapy should be initiated sooner, according to new guidelines published by the American Heart Association (AHA) and American College of Cardiology (ACC). Eleven other medical organizations endorsed the new guidelines, which replace those issued in 2017.

A new risk stratification tool A new risk stratification tool known as CA4TCH — which relies solely on clinical history — could help predict which patients with a suspected hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) will have a hypersensitivity confirmed during a drug provocation test.

First Major Guidelines Issued for Left Atrial Appendage Occlusion Devices Created to address the “uncertainty and practice variation” that surrounds transcatheter left atrial appendage occlusion (LAAO), the Society for Cardiovascular Angiography and Interventions and the Heart Rhythm Society have published jointly the first set of guidelines for the use of the procedure.

Your Heart May Be Older Than You Think Some people are said to have old souls. Some may have old hearts, too. Many Americans, particularly men with less education, lower income, and those from certain minority groups, have a “heart age” that is much older than what the calendar may indicate.